Cross-Site Multiomic Analysis Identifies Three Clinically Distinct Neuroendocrine Tumor Subtypes
A cross-site multiomic analysis of 194 patients has uncovered three distinct molecular subtypes of neuroendocrine tumors that provide prognostic value ...

